Skip to main content
MEHA
NASDAQ Life Sciences

Functional Brands Finalizes $142.9M Asset Acquisition, Existing Shareholders Face 98% Dilution

Analysis by Arik Shkolnikov
Sentiment info
Negative
Importance info
10
Price
$0.092
Mkt Cap
$3.27M
52W Low
$0.057
52W High
$8
Market data snapshot near publication time

summarizeSummary

Functional Brands Inc. has signed a definitive agreement to acquire BullionFX's Alchemy assets for $142.9 million, issuing Series D Preferred Stock that will convert into 98.28% of the company's common stock, leading to massive dilution for current shareholders.


check_boxKey Events

  • Definitive Asset Purchase Agreement Signed

    Functional Brands entered into a definitive Asset Purchase Agreement to acquire BullionFX's Alchemy assets, a blockchain-based financial ecosystem, for $142.9 million. This follows a binding Letter of Intent announced on May 11, 2026.

  • Extreme Dilution for Existing Shareholders

    The acquisition consideration involves 100,000 shares of newly created Series D Preferred Stock, which will automatically convert into common stock representing 98.28% of the company's outstanding common stock post-conversion.

  • Shareholder Approval for Conversion Post-Closing

    The conversion of the Series D Preferred Stock into common shares is contingent on shareholder approval, which will be sought after the closing of the acquisition, not before.

  • Significant Closing Conditions and Financing Needs

    The transaction is subject to numerous conditions, including a minimum $10 million equity financing, settlement of existing Series C Preferred Stock and convertible notes (up to $4 million), and resolution of pending litigation.


auto_awesomeAnalysis

This 8-K finalizes the terms of the previously announced Letter of Intent to acquire BullionFX's Alchemy assets. The definitive agreement confirms a highly dilutive transaction where Functional Brands will issue Series D Preferred Stock valued at $142.9 million, which will convert into 98.28% of the company's common stock. This effectively represents a reverse merger, fundamentally altering the company's ownership structure and future direction. The deal is critical for the company, which has a "going concern" warning and recently reported a significant net loss, but comes at an extreme cost to existing shareholders.

At the time of this filing, MEHA was trading at $0.09 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $3.3M. The 52-week trading range was $0.06 to $8.00. This filing was assessed with negative market sentiment and an importance score of 10 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed MEHA - Latest Insights

MEHA
May 22, 2026, 10:14 AM EDT
Filing Type: 8-K/A
Importance Score:
8
MEHA
May 22, 2026, 9:06 AM EDT
Filing Type: 8-K
Importance Score:
10
MEHA
May 22, 2026, 9:00 AM EDT
Source: TMX Newsfile
Importance Score:
10
MEHA
May 21, 2026, 5:15 PM EDT
Filing Type: DEFA14A
Importance Score:
9
MEHA
May 20, 2026, 5:00 PM EDT
Filing Type: 8-K
Importance Score:
8
MEHA
May 19, 2026, 5:00 PM EDT
Filing Type: DEFA14A
Importance Score:
9
MEHA
May 15, 2026, 5:11 PM EDT
Source: Wiseek News
Importance Score:
9
MEHA
May 15, 2026, 5:03 PM EDT
Filing Type: 10-Q
Importance Score:
10
MEHA
May 11, 2026, 5:45 PM EDT
Filing Type: 8-K
Importance Score:
8
MEHA
May 11, 2026, 8:10 AM EDT
Filing Type: 8-K
Importance Score:
10